SpinalKinetics

Canaccord Genuity acts as financial advisor to Spinal Kinetics, Inc. on its announced sale to Orthofix International N.V.

Canaccord Genuity is pleased to announce that on March 15, 2018, Spinal Kinetics, Inc., a privately-held developer and manufacturer of artificial cervical and lumbar discs, and Orthofix International N.V. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal health and value-added services, announced that that the two companies have entered into a definitive agreement pursuant to which Orthofix has agreed to acquire Spinal Kinetics for $45 million in cash closing consideration plus up to $60 million in contingent milestone payments related to the achievement of specific regulatory and revenue targets. The transaction is expected to close in the second quarter of 2018, subject to customary closing conditions.
Canaccord Genuity is serving as financial advisor to Spinal Kinetics and its Board of Directors in connection with the transaction.

Spinal Kinetics develops and manufactures the M6-C cervical and M6-L lumbar artificial discs for patients suffering from degenerative disc disease of the spine. The M6-C and M6-L artificial discs have rapidly established themselves among the leading artificial discs available due to the unique biomechanical properties that replicate the motion of a natural disc and the positive clinical outcomes for patients.

Orthofix is a diversified, global medical device company focused on improving patients’ lives by providing superior reconstructive and regenerative orthopedic and spine solutions to physicians worldwide.